Evidence map›Paper›PMID 41089377›Full record

ArticleBrain communications2025

Cognitive and physical activities are associated with cognitive resilience in a memory clinic cohort.

Diana I Bocancea, Anna C van Loenhoud, Bart Kuijper, Ismael L Calandri, Colin Groot, Vikram Venkatraghavan, Casper de Boer, Mara Ten Kate, Calvin Trieu, Charlotte E Teunissen and 8 more

Abstract read
In one paragraph

Article in Brain communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Diana I BocanceaAlzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam 1081 HV, The Netherlands.
Anna C van LoenhoudAlzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam 1081 HV, The Netherlands.
Bart KuijperAlzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam 1081 HV, The Netherlands.
Ismael L CalandriAlzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam 1081 HV, The Netherlands.
Colin GrootAlzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam 1081 HV, The Netherlands.
Vikram VenkatraghavanAlzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam 1081 HV, The Netherlands.ORCID https://orcid.org/0000-0001-9759-0462
Casper de BoerAlzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam 1081 HV, The Netherlands.
Mara Ten KateDepartment of Radiology and Nuclear Medicine, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam 1081 HV, The Netherlands.
Calvin TrieuAlzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam 1081 HV, The Netherlands.
Charlotte E TeunissenDepartment of Laboratory Medicine, Neurochemistry Laboratory, Amsterdam Neuroscience, Program Neurodegeneration, Vrije Universiteit Amsterdam, Amsterdam University Medical Center (Amsterdam UMC), Amsterdam 1081 HV, The Netherlands.ORCID https://orcid.org/0000-0002-4061-0837
Elsmarieke van de GiessenDepartment of Radiology and Nuclear Medicine, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam 1081 HV, The Netherlands.
Anna E LeeuwisAlzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam 1081 HV, The Netherlands.
Lisa-Marie SchlueterAlzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam 1081 HV, The Netherlands.
Argonde C van HartenAlzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam 1081 HV, The Netherlands.
Yolande A L PijnenburgAlzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam 1081 HV, The Netherlands.
Frederik BarkhofDepartment of Radiology and Nuclear Medicine, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam 1081 HV, The Netherlands.
Wiesje M van der FlierAlzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam 1081 HV, The Netherlands.ORCID https://orcid.org/0000-0001-8766-6224
Rik OssenkoppeleAlzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam 1081 HV, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lifestyle factors such as participation in cognitively stimulating activities and physical activity are hypothesized to foster neural connections and enhance resilience, thereby attenuating cognitive loss in the context of Alzheimer's disease (AD) and other neurodegenerative diseases. Nonetheless, the relationship between these factors and important clinical outcomes of cognition and brain atrophy is not well understood. We assessed cognitive and physical activity levels in a large, tertiary memory clinic cohort with various clinical and aetiological diagnoses. Furthermore, we investigated whether cognitive and physical activities relate to resilience against brain atrophy across the AD continuum. In the memory clinic-based Amsterdam Dementia Cohort (ADC), 4033 individuals completed the self-reported questionnaires to quantify their engagement in cognitive (lifetime, past and current) and physical (current) activities. Firstly, we examined differences in activity scores across diagnostic groups [i.e. Alzheimer's and non-Alzheimer's types of dementia, mild cognitive impairment (MCI) and subjective cognitive decline (SCD)] using linear models adjusted for age and sex. Secondly, in a subset on the AD continuum (i.e. amyloid-β-positive with SCD, MCI or Alzheimer's dementia;

Indexed as

Alzheimer’s diseasecognitive activitycognitive resiliencelifestyle factorsphysical activity

Identifiers

PMID41089377
PMCPMC12516313

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.